Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
Tae Hoon Lee, Joo Ho Lee, Ji Hyun Chang, Sung-Joon Ye, Tae Min Kim, Chul-Kee Park, Il Han Kim, Byoung Hyuck Kim, Chan Woo Wee
Radiat Oncol J. 2020;38(1):35-43.   Published online 2020 Mar 25     DOI: https://doi.org/10.3857/roj.2020.00052
Citations to this article as recorded by Crossref logo
Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
Clemens Seidel, Christine Viehweger, Rolf-Dieter Kortmann
Cancers.2021; 13(11): 2580.     CrossRef
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy
Nalee Kim, Do Hoon Lim, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Journal of Neuro-Oncology.2021; 154(2): 207.     CrossRef
Advances in treatment of elderly primary central nervous system lymphoma
Nicolas Martinez‐Calle, Lisa K. Isbell, Kate Cwynarski, Elisabeth Schorb
British Journal of Haematology.2021;[Epub]     CrossRef
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma
Nalee Kim, Do Hoon Lim, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Journal of Neuro-Oncology.2021;[Epub]     CrossRef
Faut-il moduler les contraintes de dose dans les organes à risque lors d’une irradiation en association avec un traitement anticancéreux systémique ?
E. Jouglar, J. Doyen, S. Supiot
Cancer/Radiothérapie.2020; 24(6-7): 594.     CrossRef